Stratos LV/LV-T Technical Manual 25

Table 2: Atrial Fibrillation Demographics at Enrollment

Characteristic

Group 1

Group 2

Group 3

P-value*

Classification of

 

 

 

 

 

 

 

Atrial Fibrillation

 

N=42

 

N=50

 

N=24

0.537

Persistent AF

10

(23.8%)

17 (34%)

6 (25%)

 

Permanent AF

32

(76.2%)

33 (66%)

18 (75%)

 

Classification of

 

 

 

 

 

 

 

Symptoms Related

 

 

 

 

 

 

 

to AF

 

N=42

 

N=49

 

N=25

 

Palpitations

32

(76.2%)

34

(69.4%)

14

(56.0%)

0.236

Chest Pain

6 (14.3%)

7 (14.3%)

3 (12.0%)

1.000

Dyspnea or shortness

36

(85.7%)

40

(81.6%)

19

(76.0%)

0.568

of breath

34

(81.0%)

45

(91.8%)

18

(72.0%)

0.149

Fatigue

Lightheadedness or

17

(40.5%)

13

(26.5%)

9 (36.0%)

0.329

syncope

9 (21.4%)

11

(22.4%)

10

(40.0%)

0.205

Other

 

 

 

 

 

 

 

Previous AF

 

 

 

 

 

 

 

Ablation

 

N=42

 

N=50

 

N=25

0.354

No

37

(88.1%)

47

(94.0%)

21

(84.0%)

 

Yes

5 (11.9%)

3

(6.0%)

4 (16.0%)

 

Past Medications

 

 

 

 

 

 

 

for Rate or Rhythm

 

 

 

 

 

 

 

Control

 

 

 

 

 

 

 

Amiodarone

 

N=41

 

N=48

 

N=24

 

Digoxin

 

 

 

0.192

12

(29.3%)

10

(20.8%)

10

(41.7%)

Diltiazem

17

(41.5%)

22

(45.8%)

13

(54.2%)

0.683

Disopyramide

17

(41.5%)

23

(47.9%)

12

(50.0%)

0.804

Dofetilide

0

(0.0%)

3

(6.3%)

0

(0.0%)

0.228

Flecanide

4

(9.8%)

3

(6.3%)

2

(8.3%)

0.895

Ibutilide

5 (12.2%)

5 (10.4%)

1

(4.2%)

0.656

Procainamide

0

(0.0%)

0

(0.0%)

1

(4.2%)

0.215

0

(0.0%)

2

(4.2%)

0

(0.0%)

0.506

Propafenone

2

(4.9%)

4

(8.3%)

0

(0.0%)

0.423

Sotolol

9 (22.0%)

10

(20.8%)

2

(8.3%)

0.389

Verapamil

5 (12.2%)

8 (16.7%)

3 (12.5%)

0.829

Metoprolol

19

(46.3%)

28

(58.3%)

10(41.7%)

0.382

Propranolol

0

(0.0%)

0

(0.0%)

1

(4.2%)

0.215

Other Beta-Blockers

7 (17.1%)

15

(31.3%)

4 (16.7%)

0.248

Other Medications

5 (12.2%)

5 (10.4%)

1

(4.2%)

0.656